Oxycodone and Application site perspiration - a phase IV clinical study of FDA data

Summary:

Application site perspiration is reported as a side effect among people who take Oxycodone (oxycodone hydrochloride), especially for people who are female, 40-49 old, also take Butrans, and have Mental disorder.

The phase IV clinical study analyzes which people have Application site perspiration when taking Oxycodone. It is created by eHealthMe based on reports of 159,853 people who have side effects when taking Oxycodone from the FDA, and is updated regularly.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

What is Application site perspiration?

Application site perspiration (production of fluids secreted by the sweat glands in the skin of mammals at application site) is found to be associated with 20 drugs and 96 conditions by eHealthMe. Check the latest studies of Application site perspiration.

On Jul, 07, 2026

159,853 people reported to have side effects when taking Oxycodone.
Among them, 25 people (0.02%) have Application site perspiration.

Could Oxycodone cause Application site perspiration?

Among these 25 people:

What is the gender of people who have Application site perspiration when taking Oxycodone? *

female: 91.3 %
male: 8.7 %

What is the age of people who have Application site perspiration when taking Oxycodone? *

What are other drugs people take besides Oxycodone? *

Butrans: 20 people, 80.00%
Topiramate: 10 people, 40.00%
Duloxetine Hydrochloride: 6 people, 24.00%
Quetiapine Fumarate: 4 people, 16.00%
Celebrex: 2 people, 8.00%
Fentanyl Transdermal System: 2 people, 8.00%
Xanax: 1 person, 4.00%
Lisinopril: 1 person, 4.00%
Lidoderm: 1 person, 4.00%
Lasix: 1 person, 4.00%

What are other side effects people have besides Application site perspiration? *

Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 20 people, 80.00%
Drug Effect Decreased: 2 people, 8.00%
Weight Decreased: 1 person, 4.00%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 4.00%
Rosacea (a skin condition that causes facial redness): 1 person, 4.00%
Hyperhidrosis (abnormally increased sweating): 1 person, 4.00%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 1 person, 4.00%
Drug Ineffective: 1 person, 4.00%
Blood Testosterone Decreased: 1 person, 4.00%
Application Site Vesicles (small bubble within a cell at application site): 1 person, 4.00%

What are the existing conditions these people have? *

Migraine (headache): 20 people, 80.00%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 20 people, 80.00%
Muscle Spasms (muscle contraction): 19 people, 76.00%
Headache (pain in head): 19 people, 76.00%
Muscle Aches (muscle pain): 9 people, 36.00%
Asthma: 3 people, 12.00%
Breakthrough Pain: 3 people, 12.00%
High Blood Cholesterol: 2 people, 8.00%
High Blood Pressure: 2 people, 8.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and have Application site perspiration?

- Check whether Application site perspiration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxycodone:

Oxycodone (162,592 reports)

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site perspiration:

Application site perspiration (20 drugs)

Browse all the conditions that are associated with Application site perspiration:

Application site perspiration (96 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycodone) and Oxycodone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.